We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+15.67%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$55B
AUM Growth
+$9.39B
(+21%)
Cap. Flow
+$2.93B
Cap. Flow
% of AUM
5.33%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,453
New
57
Increased
842
Reduced
455
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$721M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$188M |
| 3 |
RTX Corp
RTX
|
+$182M |
| 4 |
Keysight
KEYS
|
+$166M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$328M |
| 2 |
Guidewire Software
GWRE
|
+$193M |
| 3 |
Tradeweb Markets
TW
|
+$188M |
| 4 |
Domino's
DPZ
|
+$168M |
| 5 |
Amgen
AMGN
|
+$163M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 30.72% |
| 2 | Technology | 30.7% |
| 3 | Healthcare | 8.19% |
| 4 | Financials | 8.05% |
| 5 | Energy | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
VanEck International High Yield Bond ETF
IHY
$43.3M
| $84K | ﹤0.01% |
4,041
| – | – |
|
1252
Beyond Meat
BYND
$322M
| $83K | ﹤0.01% |
9,361
-184,161
| -95% | -$1.45M |
|
1253
Teledyne Technologies
TDY
$31.9B
| $81K | ﹤0.01% |
181
+34
| +23% | +$13.6K |
|
|
CBD
1254
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $81K | ﹤0.01% |
101,665
+5,930
| +6% | +$4.19K |
|
|
BPMC
1255
DELISTED
Blueprint Medicines
BPMC
| $80K | ﹤0.01% |
872
+193
| +28% | +$12.5K |
|
1256
Equitable Holdings
EQH
$14B
| $80K | ﹤0.01% |
+2,401
| New | +$70.3K |
|
|
UHT
1257
Universal Health Realty Income Trust
UHT
$584M
| $78K | ﹤0.01% |
1,803
+296
| +20% | +$12.1K |
|
1258
Evolent Health
EVH
$345M
| $77K | ﹤0.01% |
2,317
+222
| +11% | +$6.28K |
|
1259
Teladoc Health
TDOC
$1.26B
| $77K | ﹤0.01% |
3,589
+606
| +20% | +$11.2K |
|
1260
National Fuel Gas
NFG
$7.56B
| $76K | ﹤0.01% |
1,509
-128
| -8% | -$6.61K |
|
1261
Ultragenyx Pharmaceutical
RARE
$2.45B
| $75K | ﹤0.01% |
1,578
+400
| +34% | +$15.5K |
|
|
STKL
1262
DELISTED
SunOpta
STKL
| $75K | ﹤0.01% |
13,789
-1,033
| -7% | -$4.52K |
|
|
PINC
1263
DELISTED
Premier
PINC
| $74K | ﹤0.01% |
3,289
+601
| +22% | +$12.4K |
|
1264
Arrowhead Research
ARWR
$12.3B
| $73K | ﹤0.01% |
2,395
+447
| +23% | +$11.9K |
|
1265
Azenta
AZTA
$1.45B
| $73K | ﹤0.01% |
1,114
+24
| +2% | +$1.3K |
|
1266
Guardant Health
GH
$21.9B
| $73K | ﹤0.01% |
2,702
+614
| +29% | +$16.1K |
|
1267
Bentley Systems
BSY
$10.8B
| $72K | ﹤0.01% |
+1,375
| New | +$70.6K |
|
|
FOLD
1268
DELISTED
Amicus Therapeutics
FOLD
| $66K | ﹤0.01% |
4,657
+873
| +23% | +$9.91K |
|
1269
VanEck Preferred Securities ex Financials ETF
PFXF
$2.47B
| $65K | ﹤0.01% |
3,795
| – | – |
|
|
RCM
1270
DELISTED
R1 RCM Inc. Common Stock
RCM
| $65K | ﹤0.01% |
6,141
+1,044
| +20% | +$11.8K |
|
1271
VanEck BDC Income ETF
BIZD
$1.61B
| $64K | ﹤0.01% |
3,996
| – | – |
|
1272
Itron
ITRI
$4.59B
| $64K | ﹤0.01% |
850
-45
| -5% | -$2.93K |
|
|
JBTM
1273
JBT Marel
JBTM
$6.44B
| $64K | ﹤0.01% |
642
| – | – |
|
1274
New Jersey Resources
NJR
$5.57B
| $63K | ﹤0.01% |
1,421
-527
| -27% | -$22.5K |
|
1275
BlackSky Technology
BKSY
$1.02B
| $61K | ﹤0.01% |
5,418
+1,337
| +33% | +$13.6K |
|
Similar funds
VanEck Associates's Q4 2023 Portfolio in Review
As of Q4 2023, VanEck Associates held 1,453 positions worth $55B, up 21% from $45.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
VanEck Associates deployed $2.93B of net new capital in Q4 2023, opening 57 new positions and adding to 842 existing holdings. Its largest new stake was Caterpillar: 75,101 shares worth $22.2M.
By sector, the portfolio is most concentrated in Materials at 31% of assets, up from 29% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was TSMC, an estimated $328M trimmed.
- VanEck Associates's largest Q4 2023 buy was Caterpillar: 75,101 shares worth $22.2M.
- VanEck Associates added most to Newmont in Q4 2023, an estimated $721M increase.
- VanEck Associates's biggest Q4 2023 reduction was TSMC, cutting an estimated $328M.
- VanEck Associates fully exited Lithium Americas Corp. Common Shares in Q4 2023, selling an estimated $28.3M.
- VanEck Associates's ten largest holdings make up 24% of its $55B portfolio in Q4 2023.
- VanEck Associates opened 57 new positions and closed 60 in Q4 2023.
- VanEck Associates's portfolio value rose 21% quarter-over-quarter to $55B.
Based on VanEck Associates's 13F filing for Q4 2023, filed 5 Feb 2024.